Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

After Successful Screening of 2,500 patients as part of a Pilot Project with Kanhoor Medical Co, DIAGNOS will Now Screen 35,000 patients in the Kingdom of Saudi Arabia

GlobeNewswire February 27, 2018

Arrowhead Business and Investment Decisions Initiates Analyst Coverage of DIAGNOS

GlobeNewswire January 25, 2018

DIAGNOS Announces that the Next Release of its CARA Artificial Intelligence Platform Will Rely on Blockchain Technology for Security Control of Medical Records

GlobeNewswire January 17, 2018

DIAGNOS Announces the Management of the Flagship Nuevo Yo Program by Novo Nordisk

GlobeNewswire January 10, 2018

DIAGNOS Successfully Passed ISO Annual Surveillance Audit

MarketWire Canada December 19, 2017

DIAGNOS Receives Support from Export Development Canada (EDC) for the Issuance of a Performance Bond for the ISSSTE Contract

Marketwired December 6, 2017

DIAGNOS Hires Investor Relation Firm Arrowhead Business and Investment Decisions, LLC and Grants Stock Options

MarketWire Canada November 29, 2017

DIAGNOS Announces a Second Contract for Its Cardio Platform with a Multinational Pharmaceutical Company and the Resignation of a Director

MarketWire Canada November 22, 2017

DIAGNOS Announces New Project with Cardiology Department of the Centre National de Medecine du Sport C.N.M.S Hospital located in Alger, Algeria, before product launch

Marketwired November 9, 2017

DIAGNOS Announces a One-Year Agreement in North Africa with a Major Pharmaceutical Company after Successful Pilot

MarketWire Canada October 24, 2017

DIAGNOS Closes Second Tranche of Private Placement

MarketWire Canada October 23, 2017

DIAGNOS Announces a New Partner in Cambodia, Garuda Health Services

MarketWire Canada October 17, 2017

DIAGNOS Announces Closing of a Private Placement

Marketwired October 16, 2017

DIAGNOS Announces DTC Eligibility of its Common Shares in the US

MarketWire Canada September 26, 2017

DIAGNOS Provides Timelines on Cardiovascular Disease (CVD) Prevention Test Development and Commercialization Plans

MarketWire Canada September 19, 2017

DIAGNOS Announces Restatement of March 31, 2017 Financial Statements which Resulted in a Decrease in Expenses of $2,491,096

Marketwired August 28, 2017

DIAGNOS Announces 2 screening clinics with Al Kahhal Medical Complex in the Kingdom of Saudi Arabia

MarketWire Canada August 22, 2017

AdCare Health Systems Reports Second Quarter 2017 Financial Results

PR Newswire August 14, 2017

DIAGNOS Announces Results from the Annual Meeting of Shareholders, Appointments of new Chairman and new Chief Medical Officer and Stock Options Grant

MarketWire Canada August 14, 2017

AdCare Schedules Conference Call to Discuss Second Quarter 2017 Financial Results

PR Newswire July 31, 2017